BDNF, GDNF, and VEGF in Muller Cell Viability: Implication in Neuroprotection in Diabetic Retinopathy and in Anti-VEGF Therapies

被引：0
|
作者：
Le, Yun-Zheng
Zhu, Meili
机构：
来源：
DIABETES | 2017年 / 66卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
40-LB
引用
收藏
页码：LB10 / LB11
页数：2
相关论文
共 50 条
  • [21] Effect of Intravitreal Anti-VEGF Therapy on the Severity of Diabetic Retinopathy
    Kim E.L.
    Moshfeghi A.A.
    Current Ophthalmology Reports, 2016, 4 (2) : 61 - 70
  • [22] Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: A review
    Tan, Yiran
    Fukutomi, Akira
    Sun, Michelle T.
    Durkin, Shane
    Gilhotra, Jagjit
    Chan, Weng Onn
    SURVEY OF OPHTHALMOLOGY, 2021, 66 (06) : 926 - 932
  • [23] A review of clinical trials of anti-VEGF agents for diabetic retinopathy
    Nicholson, Benjamin P.
    Schachat, Andrew P.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (07) : 915 - 930
  • [24] Anti-VEGF Effects of Intravitreal Erythropoietin in Early Diabetic Retinopathy
    Zhong, I.
    Hu, L. -M.
    Xu, G.
    Wu, Y.
    Shen, I.
    Luo, Y.
    Zhong, Y.
    Sinclair, S. H.
    Li, W.
    Xu, G. -T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [25] Beyond anti-VEGF: Treatment of diabetic retinopathy through neuropeptides
    Liu, Lei
    Ou, Kepeng
    Schrader, Stefan
    Dick, Andrew
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 47 : 63 - 64
  • [26] A review of clinical trials of anti-VEGF agents for diabetic retinopathy
    Benjamin P. Nicholson
    Andrew P. Schachat
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 915 - 930
  • [27] Choroidal thickness in diabetic retinopathy: the role of anti-VEGF therapy
    Lains, Ines
    Figueira, Joao
    Santos, Ana Rita
    Baltar, Alda
    Costa, Miguel
    Nunes, Sandrina
    Farinha, Claudia
    Pinto, Rita
    Henriques, Jose
    Silva, Rufino
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [28] Effects of glycemic control on anti-VEGF regimens in the management of diabetic retinopathy
    Chang, Thomas
    Adelman, Ron A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [29] Variable dosing of Anti-VEGF Therapy in the Management of Proliferative Diabetic Retinopathy
    Gonzalez, Victor H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [30] Intravitreal Anti-VEGF Treatment as Adjunctive Treatment in the Management of Diabetic Retinopathy
    Carifi, Gianluca
    Zygoura, Vasiliki
    Kopsachilis, Nikolaos
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 30 (04) : 303 - 303
12345